Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sinoatrial (SA) node depolarization refers to the process by which specialized pacemaker cells in the SA node of the heart spontaneously generate an action potential, initiating each heartbeat. The SA node is located in the upper back wall of the right atrium and is composed of pacemaker cells that lack a true resting membrane potential. Instead, these cells exhibit a continuous cycle of spontaneous depolarization and repolarization, making them responsible for setting the pace of cardiac rhythm. Key ion channels involved include funny channels (If), T-type Ca²⁺ channels, L-type Ca²⁺ channels, Na⁺-Ca²⁺ exchanger, and potassium channels. The autonomic nervous system tightly regulates SA node automaticity, with sympathetic stimulation increasing heart rate and parasympathetic stimulation decreasing heart rate.
N/A - This is a physiological process, not a drug target, but drugs can influence the process.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sinoatrial Node Depolarization (SAN Depolarization).